 | Up a level |
Diletti, Roberto; Garcia-Garcia, Hector M.; Bourantas, Christos V.; van Geuns, Robert Jan; Van Mieghem, Nicolas M.; Vranckx, Pascal; Zhang, Yao-Jun; Farooq, Vasim; Iqbal, Javaid; Wykrzykowska, Joanna J.; de Vries, Ton; Swart, Michael; Teunissen, Yvonne; Negoita, Manuela; van Leeuwen, Frank; Silber, Sigmund; Windecker, Stephan; Serruys, Patrick W. (2013). Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial. Heart, 99(17), pp. 1267-1274. BMJ Publishing Group 10.1136/heartjnl-2013-303778
Vranckx, Pascal; McFadden, Eugene; Cutlip, Donald E; Mehran, Roxana; Swart, Michael; Kint, P P; Zijlstra, Felix; Silber, Sigmund; Windecker, Stephan; Serruys, Patrick W C J (2013). Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation. Contemporary clinical trials, 34(1), pp. 53-9. New York, N.Y.: Elsevier 10.1016/j.cct.2012.08.012
Farooq, Vasim; Vergouwe, Yvonne; Räber, Lorenz; Vranckx, Pascal; Garcia-Garcia, Hector; Diletti, Roberto; Kappetein, Arie Pieter; Morel, Marie Angèle; de Vries, Ton; Swart, Michael; Valgimigli, Marco; Dawkins, Keith D; Windecker, Stephan; Steyerberg, Ewout W; Serruys, Patrick W (2012). Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. European Heart Journal, 33(24), pp. 3098-104. Oxford: Oxford University Press 10.1093/eurheartj/ehs295
Garg, Scot; Sarno, Giovanna; Girasis, Chrysafios; Vranckx, Pascal; de Vries, Ton; Swart, Michael; Bressers, Marco; Garcia-Garcia, Hector M; van Es, Gerrit-Anne; Räber, Lorenz; Campo, Gianluca; Valgimigli, Marco; Dawkins, Keith D; Windecker, Stephan; Serruys, Patrick W (2011). A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC. Cardiovascular Interventions, 4(6), pp. 645-53. New York, N.Y.: Elsevier 10.1016/j.jcin.2011.02.018
